I'm a retired research chemist/physicist with Parkinson's disease and I've been working on upregulating Nrf2 with sulforaphane to fight oxidative stress.
The results I achieved on my PD and with a group of 8 people with PD have shown that sulforaphane strongly attenuated non-motor symptoms especially fatigue and lack of motivation, suggesting that the first target for Nrf2 seems to be mitochondria. I am not an expert in this subject and I would like to reach out to research groups and Parkinson's disease specialists to discuss how to take this idea further.
You can find the background here :
https://wp.me/pc57vK-1o
And a preprint I have written on RG here:
https://www.researchgate.net/deref/http%3A%2F%2Fdx.doi.org%2F10.13140%2FRG.2.2.21776.43529%2F1?_sg%5B0%5D=kBzth1rfHVPs90_iOo3imbsNXVH6sRTguWcBiNWL12tDLz1PNQbsHriCxD3J8KqOh_x9wa5qK7NL6_hUlYz-BzlnYQ.JSTdcyKA5S1eXqc7LbM79Ek1ACtUTv44hsbD4bFiifFwxN6PGEvCcC45xHKgho96cM6fmsJ__Bju8FXvDU9C_w